Form 8-K Alto Neuroscience, Inc. For: Oct 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Alto Neuroscience (ANRO) PT Lowered to $10 at Baird
October 23, 2024 6:24 AM EDTBaird analyst Brian Skorney lowered the price target on Alto Neuroscience (NYSE: ANRO) to $10.00 (from $32.00) while maintaining a Outperform rating.
The analyst comments "Lowering price target to $10 on ALTO-100 failure. Alto's first shot at its precision psychiatry approach failed to materialize... More
